EGFR and cancer: To ensure that the 6 month time window to capture EGFR testing was sufficient, we also evaluated the time from cancer diagnosis to EGFR testing, and found that close to half (46.7%) of these patients received the testing during the month of diagnosis, 34.6% received it in the month after diagnosis, and only 1.4% received the testing in the 6th month after diagnosis.